FDA denies Teva Copaxone generic trials petition

Company hopes generic versions of MS drug will be delayed by clinical trials.

By SHIRI HABIB-VALDHORN
December 6, 2012 00:01
Teva Pharmaceutical plant is seen in Jerusalem

Teva 311. (photo credit: REUTERS/Ronen Zvulun)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS